Alfasigma S.p.a.

This study looks at the long-term safety of the drug filgotinib in adults with ulcerative colitis. Participants had already taken filgotinib in an earlier study. The main goal is to track side effects and lab test changes over time.

This study follows over 1,300 adults with moderate to severe rheumatoid arthritis who are taking filgotinib as part of their normal care. Researchers want to see how long patients stay on the drug and how it affects pain, fatigue, and daily life. The goal is to understand the dru…

This study follows about 500 adults with moderate to severe ulcerative colitis who are starting filgotinib, a daily pill. Researchers want to see how long people stay on the drug, how well it controls symptoms, and how it affects quality of life in real-world settings. The goal i…

This study tests whether a daily pill called filgotinib can reduce pain and stiffness in people with active axial spondyloarthritis, a type of arthritis that mainly affects the spine. About 495 adults with the condition will receive either 200 mg, 100 mg of filgotinib, or a place…